Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
September 30, 2026 2.411M
June 30, 2026 13.68M
March 31, 2026 5.457M
December 31, 2025 4.009M
September 30, 2025 -4.669M
June 30, 2025 1.979M
March 31, 2025 -14.07M
December 31, 2024 2.997M
September 30, 2024 -5.375M
June 30, 2024 28.63M
March 31, 2024 47.59M
December 31, 2023 -55.37M
September 30, 2023 33.43M
June 30, 2023 29.58M
March 31, 2023 16.53M
December 31, 2022 11.61M
September 30, 2022 7.953M
June 30, 2022 31.24M
March 31, 2022 31.96M
December 31, 2021 -92.51M
Date Value
September 30, 2021 -185.60M
June 30, 2021 0.074M
March 31, 2021 -0.024M
December 31, 2020 0.00
September 30, 2020 -2.45M
June 30, 2020 0.00
March 31, 2020 0.00
December 31, 2019 -0.0227M
September 30, 2019 -0.0087M
June 30, 2019 -0.0296M
March 31, 2019 0.00
December 31, 2018 -0.0118M
September 30, 2018 -0.1305M
June 30, 2018 -0.1776M
March 31, 2018 -0.0118M
December 31, 2017
September 30, 2017 -0.2741M
June 30, 2017 -0.3904M
March 31, 2017 -0.0715M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. -1.032B
Bio-Rad Laboratories, Inc. -145.90M
Bruker Corp. -72.70M
Danaher Corp. -300.00M
Harvard Bioscience, Inc. -1.343M